Page last updated: 2024-08-17

carbostyril and Hypertension, Pulmonary

carbostyril has been researched along with Hypertension, Pulmonary in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdul-Salam, VB; Ahmetaj-Shala, B; Aldabbous, L; Dubois, OD; Duluc, L; Iannone, L; Mahomed, AS; Mitchell, J; Oliver, E; Storck, EM; Tate, EW; Wilkins, MR; Wojciak-Stothard, B; Zhao, L1
Merkus, D; Schermuly, RT1
Al-Tamari, HM; Capecchi, MR; Grimminger, F; Kojonazarov, B; Muecke, C; Pullamsetti, SS; Savai, R; Schermuly, RT; Sedding, D; Seeger, W; Teske, R; Weissmann, N1
Bai, F; Blaskovich, MA; Chen, X; Djeu, JY; Edwards, TD; Epling-Burnette, PK; Loughran, TP; Moscinski, L; Painter, JS; Sebti, S; Sokol, L; Wei, S; Yoder, JA; Zhou, J; Zou, J1
Gillissen, A; Häussermann, A1
Chaumais, MC; De Man, FS; Dorfmüller, P; Eddahibi, S; Fadel, E; François, C; Girerd, B; Guignabert, C; Huertas, A; Humbert, M; Lecerf, F; Montani, D; Perros, F; Tu, L1

Reviews

1 review(s) available for carbostyril and Hypertension, Pulmonary

ArticleYear
[Diseases of the lung and air passages 2010].
    Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:25-26

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aminopyridines; Asthma; Benzamides; Cyclopropanes; Drug Therapy, Combination; Humans; Hypertension, Pulmonary; Indans; Lung Diseases; Lung Neoplasms; Neoplasm Staging; Phosphodiesterase 4 Inhibitors; Pneumonia, Bacterial; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones

2010

Other Studies

5 other study(ies) available for carbostyril and Hypertension, Pulmonary

ArticleYear
Tipifarnib prevents development of hypoxia-induced pulmonary hypertension.
    Cardiovascular research, 2017, 03-01, Volume: 113, Issue:3

    Topics: Animals; Antihypertensive Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Hypertension, Pulmonary; Hypoxia; Male; Mice, Inbred C57BL; Phenotype; Protein Prenylation; Proteomics; Pulmonary Artery; Quinolones; rhoB GTP-Binding Protein; Time Factors; Transfection; Vasoconstriction; Vasodilation

2017
Farnesylation of RhoB: the cancer hypothesis of pulmonary hypertension revisited.
    Cardiovascular research, 2017, 03-01, Volume: 113, Issue:3

    Topics: Humans; Hypertension, Pulmonary; Hypoxia; Neoplasms; Prenylation; Quinolones; rhoB GTP-Binding Protein

2017
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension.
    Nature medicine, 2014, Volume: 20, Issue:11

    Topics: Adult; Animals; Apoptosis; Bone Morphogenetic Proteins; Bromodeoxyuridine; Cell Proliferation; Cytokines; Female; Forkhead Transcription Factors; Gene Deletion; Gene Expression Regulation; Humans; Hypertension, Pulmonary; Intercellular Signaling Peptides and Proteins; Lung; Male; Mice; Muscle, Smooth, Vascular; Paclitaxel; Pulmonary Artery; Quinolones; Rats; RNA, Messenger; Signal Transduction; Small Molecule Libraries; Vascular Remodeling

2014
Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling.
    Blood, 2008, Dec-01, Volume: 112, Issue:12

    Topics: Antineoplastic Agents; Cells, Cultured; Enzyme Inhibitors; Farnesyltranstransferase; Female; Humans; Hypertension, Pulmonary; K562 Cells; Leukemia, Large Granular Lymphocytic; Middle Aged; Quinolones; Receptors, Natural Killer Cell; Signal Transduction; Treatment Outcome

2008
A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
    American journal of respiratory and critical care medicine, 2012, Oct-01, Volume: 186, Issue:7

    Topics: Animals; Benzamides; Benzimidazoles; Case-Control Studies; Crk-Associated Substrate Protein; Disease Models, Animal; Endothelial Cells; Epidermal Growth Factor; Familial Primary Pulmonary Hypertension; Fibroblast Growth Factor 2; Gefitinib; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Mice; Monocrotaline; Myocytes, Smooth Muscle; Piperazines; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Pulmonary Artery; Pyrimidines; Quinazolines; Quinolones; Rats; Signal Transduction

2012